Variability of QT interval measurements in opioid-dependent patients on methadone

CJAM Canadian Journal of Addiction Medicine

Volumn 5, Issue 2, 2014, Pages 10-16

  Worster, Andrew ^a   Varenbut, Michael ^b   Daiter, Jeff ^b   Nair, Girish M ^b   Plater Zyberk, Carolyn ^b   Griffith, Lauren ^b   Ma, Jihui ^b   Zachos, Constantine ^b   Sivilotti, Marco L A ^b  

^a HAMILTON GENERAL HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE;

ADULT; ARTICLE; BAZETT FORMULA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAPHY; FRAMINGHAM RISK SCORE; HEART RATE; HEART VENTRICLE ARRHYTHMIA; HUMAN; MEASUREMENT ACCURACY; NOMOGRAM; OPIATE ADDICTION; OUTCOME ASSESSMENT; QT INTERVAL; QT PROLONGATION; RISK ASSESSMENT; SINGLE DRUG DOSE; ACCURACY; AUTOANALYSIS; CARDIOVASCULAR RISK; COHORT ANALYSIS; INTERMETHOD COMPARISON; MEASUREMENT REPEATABILITY; PROSPECTIVE STUDY; TORSADE DES POINTES;

EID: 84903792759     PISSN: 19231210     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Farrell, M, et al. Methadone maintenance treatment in opiate dependence: a review. BMJ. 1994;309(6960):997-1001.
2. Strain, EC, et al. Dose-response effects of methadone in the treatment of opioid dependence. Ann Intern Med. 1993;119(1):23-7.
3. Newman, RG, and Whitehill, WB. Double-blind comparison of methadone and placebo maintenance treatments of narcotic addicts in Hong Kong. Lancet. 1979;2(8141):485-8.
4. Dole, VP, et al. Methadone treatment of randomly selected criminal addicts. N Engl J Med. 1969;280(25):1372-5.
5. Gunne, LM, and Gronbladh, L. The Swedish methadone maintenance program: a controlled study. Drug Alcohol Depend. 1981;7(3):249-56.
6. Caplehorn, JR, et al. Retention in methadone maintenance and heroin addicts' risk of death. Addiction. 1994;89(2):203-9.
7. Ball, JC, et al. Reducing the risk of AIDS through methadone maintenance treatment. J Health Soc Behav. 1988;29(3):214-26.
8. Caplehorn, JR, and Ross, MW. Methadone maintenance and the likelihood of risky needle-sharing. Int J Addict. 1995;30(6):685-98.
9. Zhang, Z, Friedmann, PD, and Gerstein, DR. Does retention matter? Treatment duration and improvement in drug use. Addiction. 2003;98(5):673-84.
10. Dole, VP, and Joseph, H. Long-term outcome of patients treated with methadone maintenance. Ann N Y Acad Sci. 1978;311:181-9.
11. Fairbank, JA, Dunteman, GH, and Condelli, WS. Do methadone patients substitute other drugs for heroin? Predicting substance use at 1-year follow-up. Am J Drug Alcohol Abuse. 1993; 19(4):465-74.
12. Mattick, RP, et al, Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev, 2003(2): p. CD002209.
13. Pani PP, Trogu E, Maremmani I, Pacini M. QTc interval screening for cardiac risk in methadone treatment of opioid dependence. Cochrane Database Syst Rev. 2013; 20;6:CD008939.
14. QT/QTc Interval Prolongation: Guidance for Product Monograph Content pp13 Published by authority of the Ministry of Health.http://www.hc-sc.gc.ca/dhp-mps/prodpharma/ applic-demande/guide-ld/qtqtc/qt_pm_mp-eng.php
15. Methadone Maintenance Treatment Program Standards and Clinical Guidelines 4th Edition February 2011.College of Physicians and Surgeons of Ontario pp148.
16. Isbister GK, Page CB. Drug induced QT prolongation: the measurement and assessment of the QT interval in clinical practice. Br J Clin Pharmacol. 2013;76(1):48-57.
17. Guidance for Industry: E14 Clinical evaluation of QTc interval prolongation and proarrhythmic potential for nonantiarrhythmic drugs. http://www.hc-sc.gc.ca/dhp-mps/prodpharma/ applic-demande/guide-ld/ich/efficac/e14-eng.php
18. Postema PG, De Jong JSSG, Van der Bilt IAC et.al. Accurate electrocardiographic assessment of the QT interval: Teach the tangent. Heart Rhythm 2008;5:1015-1018.
19. Malik M. Errors and misconceptions in ECG measurement used for the detection of drug induced QT interval prolongation. Journal of Electrocardiology. 2004; 37: 25-33.
20. Luo S, Michler K, Johnston P and Macfarlane PW. A comparison of commonly used QT correction formulae: The effect of heart rate on the QTc of normal ECGs. Journal of Electrocardiology. 2004;37: 81-90.
21. Goldenberg I, Moss AJ and Zareba W. QT Interval; How to measure it and what is "Normal". J Cardiovasc Electrophysiology. 2006;17:333-336.
22. Panicker GK, et al. Z-score for benchmarking reader competence in a central ECG laboratory. Ann Noninvasive Electrocardiol. 2009;14(1):19-25.
23. Chan A, Isbister GK, Kirkpatrick CM, Dufful SB. Druginduced QT prolongation and torsades de pointes: evaluation of a QT nomogram. QJM. 2007;100(10):609-15.
24. Bland JM, Altman DG: Measuring agreement in method comparison studies. Stat Meth Med Res. 1999;8:135-160.
25. Bland JM, Altman DG: Agreement between methods of measurement with multiple observations per individual. J Biopharm Stat. 2007;17(4):571-582.
26. Anchersen K, Clausen T, Gossop M, Hansteen V, Waal H. Prevalence and clinical relevance of corrected QT interval prolongation during methadone and Buprenorphine treatment: a mortality assessment study. Addiction. 2009;104(6):993-9.
27. Fanoe S, Jensen GB, Sjøgren P, Korsgaard MP, Grunnet M. Oxycodone is associated with dose-dependent QTc prolongation in patients and low-affinity inhibiting of hERG activity in vitro. Br J Clin Pharmacol. 2009;67(2):172-9.
28. Fonseca F, Marti-Almor J, Pastor A, Cladellas M, Farré M, de la Torre R, Torrens M. Prevalence of long QTc interval in methadone maintenance patients. Drug Alcohol Depend. 2009; 99(1-3):327-32.
29. Krantz MJ. Heterogeneous impact of methadone on the QTc interval: what are the practical implications? J Addict Dis. 2008;27(4):5-9.
30. Athanasos P, Farquharson AL, Compton P, Psaltis P, Hay J. Electrocardiogram characteristics of methadone and buprenorphine maintained subjects. J Addict Dis. 2008; 27(3):31-5.
31. Wedam EF, Bigelow GE, Johnson RE, Nuzzo PA, Haigney MC. QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial. Arch Intern Med. 2007; 167(22):2469-75.
32. Fanoe S, Hvidt C, Ege P, Jensen GB. Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen. Heart. 2007; 93(9):1051-5.
33. Peles E, Bodner G, Kreek MJ, Rados V, Adelson M. Corrected- QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients: a cross-sectional study. Addiction. 2007;102(2):289-300.
34. Martell BA, Arnsten JH, Krantz MJ, Gourevitch MN. Impact of methadone treatment on cardiac repolarization and conduction in opioid users. Am J Cardiol. 2005; 95(7):915-8.
35. Indik JH, Pearson EC, Fried K et.al. Bazett and Fridericia QT correction formulas interfere with measurement of drug-induce changes in QT interval. Heart Rhythm. 2006;3:1003-1007.